BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10567655)

  • 1. Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-kappaB activity.
    Bloss T; Kaykas A; Sugden B
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3227-3232. PubMed ID: 10567655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain.
    Coffin WF; Erickson KD; Hoedt-Miller M; Martin JM
    Oncogene; 2001 Aug; 20(38):5313-30. PubMed ID: 11536044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling.
    Kaykas A; Worringer K; Sugden B
    J Virol; 2002 Nov; 76(22):11551-60. PubMed ID: 12388716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.
    Mitchell T; Sugden B
    J Virol; 1995 May; 69(5):2968-76. PubMed ID: 7707523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis.
    Coffin WF; Geiger TR; Martin JM
    J Virol; 2003 Mar; 77(6):3749-58. PubMed ID: 12610149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variations between two Epstein-Barr virus LMP 1 variants have no effect on the activation of NF-kappaB activity.
    Yeh TS; Li SN; Wu CJ; Liu ST; Meng CL; Chang YS
    DNA Cell Biol; 1997 Nov; 16(11):1311-9. PubMed ID: 9407003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
    Takeshita H; Yoshizaki T; Miller WE; Sato H; Furukawa M; Pagano JS; Raab-Traub N
    J Virol; 1999 Jul; 73(7):5548-55. PubMed ID: 10364303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs.
    Brodeur SR; Cheng G; Baltimore D; Thorley-Lawson DA
    J Biol Chem; 1997 Aug; 272(32):19777-84. PubMed ID: 9242637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-κB.
    Ishikawa C; Mori N
    Int J Oncol; 2013 May; 42(5):1786-92. PubMed ID: 23546309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling.
    Erickson KD; Martin JM
    J Virol; 2000 Jan; 74(2):1057-60. PubMed ID: 10623774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
    Mori N; Morishita M; Tsukazaki T; Yamamoto N
    Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.
    Moorthy RK; Thorley-Lawson DA
    J Virol; 1993 Mar; 67(3):1638-46. PubMed ID: 8382313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1.
    Okudaira T; Yamamoto K; Kawakami H; Uchihara JN; Tomita M; Masuda M; Matsuda T; Sairenji T; Iha H; Jeang KT; Matsuyama T; Takasu N; Mori N
    Br J Haematol; 2006 Feb; 132(3):293-302. PubMed ID: 16409294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytoplasmic C-terminal domain but not the N-terminal domain of latent membrane protein 1 of Epstein-Barr virus is essential for B cell activation.
    Peng-Pilon M; Ruuth K; Lundgren E; Brodin P
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():767-77. PubMed ID: 9049322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.
    Grimm T; Schneider S; Naschberger E; Huber J; Guenzi E; Kieser A; Reitmeir P; Schulz TF; Morris CA; Stürzl M
    Blood; 2005 Apr; 105(8):3263-9. PubMed ID: 15613549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling.
    Shimabuku T; Tamanaha A; Kitamura B; Tanabe Y; Tawata N; Ikehara F; Arakaki K; Kinjo T
    Int J Clin Exp Pathol; 2014; 7(5):1920-34. PubMed ID: 24966902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.
    Yoshizaki T; Horikawa T; Qing-Chun R; Wakisaka N; Takeshita H; Sheen TS; Lee SY; Sato H; Furukawa M
    Clin Cancer Res; 2001 Jul; 7(7):1946-51. PubMed ID: 11448908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
    Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
    Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
    Miller WE; Edwards RH; Walling DM; Raab-Traub N
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.